We could not find any results for:
Make sure your spelling is correct or try broadening your search.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angio... KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. Show more
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVistaβs board of directors granted nine newly-hired employees inducement options to purchase...
β Delays in treating attacks lead to increased anxiety, quality of life issues, higher frequency of returning attacks, and suboptimal clinical outcomes in both on-demand and prophylaxis patients...
β Full EAMS designation would allow treatment of patients with sebetralstat prior to receiving a Marketing Authorization from UK β KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage...
- Sebetralstat Phase 3 KONFIDENT clinical trial met all endpoints and demonstrated a favorable safety profile as first oral on-demand therapy for hereditary angioedema - - CEO transition supports...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.04 | -9.01994796184 | 11.53 | 11.78 | 10.105 | 343937 | 11.14903452 | CS |
4 | -0.59 | -5.32490974729 | 11.08 | 12.4555 | 10.105 | 529313 | 11.50433405 | CS |
12 | -5.32 | -33.6495888678 | 15.81 | 16.88 | 10.105 | 831255 | 13.48475375 | CS |
26 | 2.01 | 23.7028301887 | 8.48 | 16.88 | 7.21 | 580903 | 12.62404899 | CS |
52 | 2.52 | 31.6185696361 | 7.97 | 16.88 | 7.21 | 405353 | 11.81322814 | CS |
156 | -14.12 | -57.3750507924 | 24.61 | 30.7 | 4.12 | 314485 | 12.04424969 | CS |
260 | -13.54 | -56.3462338743 | 24.03 | 45 | 4.12 | 288790 | 16.5391696 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions